Sabra Health Care REIT, Inc.
NASDAQ:SBRAREIT - Healthcare Facilities
-$0.11 today
- Market cap
- $5.40B
- Beta
- 0.63
- P/E (TTM)
- 29.0
- EPS (TTM)
- $0.62
- Dividend yield
- 6.69%
Volume 2.42M
Average 2.46M
SBRA Selling, General & Admin
Overhead costs of running the business, including sales, marketing, management, and administrative staff.
Sabra Health Care REIT, Inc.NASDAQ: SBRA
Selling, General & Admin · Q2 FY2026 · quarter ended Jun 2026
Selling, general & admin growth accelerates
Q2 FY2026 selling, general & admin of $16.82M rose 34.4% year over year, ahead of the +18.7% change in trailing-twelve-month selling, general & admin. Sequentially, it rose 13.2% from the prior quarter. Over 3 fiscal years it compounded at +10.7% a year.
Context
- Selling, general & admin amounted to 6.9% of revenue in FY2025, down 0.2 pp from a year earlier.
- Selling, general & admin increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether selling, general & admin reaches the consensus estimate from 4 analysts of $63.43M (+18.1%) for the fiscal year ending Dec 2026, a step up from the +7.3% reported in FY2025.
Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.
- Latest quarterJun 2026
- $16.82M+13.2% QoQ
- Last fiscal yearDec 2025
- $53.71M+7.3% YoY
- LTMJun 2026
- $60.15M+18.7% YoY
Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.
Selling, General & Admin history
USD · from the income statement
- Latest · FY2025
- 53.71M USD
- Year-over-year change
- +7.3%
- 4-year CAGR
- +11.6%
| Period | Period end | Selling, General & Admin | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 53.71M | +7.3% |
| FY2024 | 2024-12-31 | 50.07M | +5.5% |
| FY2023 | 2023-12-31 | 47.47M | +20.0% |
| FY2022 | 2022-12-31 | 39.57M | +14.1% |
| FY2021 | 2021-12-31 | 34.67M | — |
Selling, General & Admin vs competitors
How SBRA compares with its peers on the latest reported figures
- SBRA's LTM Jun 2026 selling, general & admin of $60.15M is the 6th highest of the 11 companies compared; the peer median is $44.64M.
- Its year-over-year change of +18.7% is the 3rd highest of 9, against a peer median of +0.5%.
- Selling, general & admin amounts to 7.0% of revenue for SBRA, versus a peer median of 6.1%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $37.58B | +35172.3% | +2.2% | 1406.7% | |
| LTM Sep 2026 | $1.76B | +633.8% | +126.5% | 12.8% | |
MPTMedical Properties Trust, Inc. | LTM Jun 2026 | $129.3M | -2.9% | -6.7% | 12.7% |
| LTM Sep 2026 | $94.32M | +4.0% | -11.6% | 4.2% | |
| LTM Jun 2026 | $64.18M | -36.0% | — | 5.0% | |
| LTM Jun 2026 | $60.15M | +18.7% | +10.7% | 7.0% | |
NHPBPNational Healthcare Properties, Inc. | LTM Mar 2026 | $25.09M | +18.4% | +11.9% | 7.3% |
NHPNational Healthcare Properties, Inc. (NHP) | LTM Dec 2025 | $24.84M | — | +11.9% | 7.3% |
| LTM Sep 2026 | $16.83M | -39.4% | — | 3.7% | |
| FY2025 | $14.72M | — | — | 1.9% | |
| LTM Sep 2026 | -$4.25M | -109.5% | -80.7% | 0.7% | |
| Peer median (excluding SBRA) | $44.64M | +0.5% | +2.2% | 6.1% | |
Competitors are the stored peer set for SBRA. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 569.55M | 624.81M | 647.51M | 703.24M | 774.63M |
| Cost of Revenue | 141.2M | 162.61M | 195.25M | 227.09M | 271.11M |
| Gross Profit | 428.34M | 462.2M | 452.27M | 476.15M | 503.53M |
| Gross Margin | 75.2% | 74.0% | 69.8% | 67.7% | 65.0% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 34.67M | 39.57M | 47.47M | 50.07M | 53.71M |
| Operating Expenses | 217.6M | 227.36M | 230.56M | 219.12M | 239.66M |
| Depreciation & Amortization | 178.99M | 187.78M | 183.09M | 169.62M | 187M |
| EBITDA | 166.21M | 216.89M | 311.81M | 412.61M | 456.83M |
| EBITDA Margin | 29.2% | 34.7% | 48.2% | 58.7% | 59.0% |
| Operating Income | 210.75M | 234.84M | 221.71M | 257.03M | 263.87M |
| Operating Margin | 37.0% | 37.6% | 34.2% | 36.5% | 34.1% |
| Interest Income | 0 | 0 | 0 | 0 | 0 |
| Interest Expense | 98.63M | 105.47M | 112.96M | 115.27M | 112.49M |
| Other Income / Expenses | (322.16M) | (311.21M) | (205.95M) | (129.31M) | (106.52M) |
| Income Before Tax | (111.41M) | (76.36M) | 15.76M | 127.72M | 157.35M |
| Pre-Tax Margin | -19.6% | -12.2% | 2.4% | 18.2% | 20.3% |
| Income Tax Expense | 1.85M | 1.24M | 2M | 1.01M | 1.84M |
| Net Income | (113.26M) | (77.61M) | 13.76M | 126.71M | 155.61M |
| Net Margin | -19.9% | -12.4% | 2.1% | 18.0% | 20.1% |
| EPS (Basic) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| EPS (Diluted) | (0.52) | (0.34) | 0.06 | 0.54 | 0.64 |
| Weighted Avg Shares | 219.07M | 230.95M | 231.2M | 233.5M | 241.31M |
| Weighted Avg Shares (Diluted) | 219.07M | 230.95M | 232.79M | 236.05M | 244.5M |
Sabra Health Care REIT, Inc.
NASDAQ:SBRA
Intrinsic Alpha fair value
Locked
Current Price
$20.62
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.